Indian pharma to take on Chinese imports of critical drugs


Apex pharma exports body Pharmaceuticals Export Promotion Council of India (Pharmexcil) is in talks with the Union government to secure manufacturing of top 100 drugs, many of which are are being imported from China.

Apex pharma exports body Pharmaceuticals Export Promotion Council of India (Pharmexcil) is in talks with the Union government to secure manufacturing of top 100 drugs, many of which are are being imported from China.

"We have requested the government to take steps to facilitate manufacturing of top 100 products that are being imported from China. Currently, we import over $3 billion worthof pharma products from China," Pharmexcil chairman and Aurobindo Pharma director M Madan Mohan Reddy said.

He said a major challenge in securing manufacturing of these drugs in India is that Chinese manufacturers operate on a larger scale, which makes them more viable. Speaking about other challenges, he said that the Indian pharma industry is reeling under a massive shortage of skilled manpower. "As an industry, we are struggling with the issue of availability of skilled manpower. In fact, the attrition rate is very high, ranging between 12 to 15% while ideally it should be around 6-7%," he added.


Comments

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

PHYTOCON 2018 - Commercialization of medicinal plant products: Lab techniques to trade_14 April 2018